Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Biogen Receives FDA Approval For Aduhelm

FDA
News

Biogen Receives FDA Approval For Aduhelm

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761178

byBenzinga Newsdesk

February 9, 2023

1 minute read

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761178

Breast Cancer Awareness: How Can Marijuana Companies Help? Listen To An Expert On Benzinga’s Cannabis Insider

By Joana Scopel

October 17, 7:37 PM

Several cannabis companies such as RISE, Ghostbudsters Farm, Verano Holdings Corp. (CSE: VRNO) (OTCQX: VRNOF) and 4Front Ventures Corp. (OTCQX: FFNTF), have launched fundraising an

CSE:VRNO

Shyfting Gears: TD Synnex’s Shyft Division Accelerates With Cokeva Acquisition

By Lekha Gupta

January 3, 7:26 AM

TD Synnex Corp (NYSE: SNX) division Shyft Global Services disclosed the acquisition of technology lifecycle service provider Cokeva, Inc.

SNX

Jefferies Initiates Coverage On Bristol-Myers Squibb with Hold Rating, Announces Price Target of $62

By Benzinga Newsdesk

March 6, 6:37 AM

Jefferies analyst Akash Tewari initiates coverage on Bristol-Myers Squibb (NYSE:BMY) with a Hold rating and announces Price Target of $62.

BMY

Evercore ISI Group Maintains Outperform on Micron Technology, Lowers Price Target to $70

By Benzinga Newsdesk

September 26, 11:01 AM

Evercore ISI Group analyst C Muse maintains Micron Technology (NASDAQ:MU) with a Outperform and lowers the price target from $85 to $70.

Biogen Receives FDA Approval For Aduhelm

Related Posts

Breast Cancer Awareness: How Can Marijuana Companies Help? Listen To An Expert On Benzinga’s Cannabis Insider

Shyfting Gears: TD Synnex’s Shyft Division Accelerates With Cokeva Acquisition

Jefferies Initiates Coverage On Bristol-Myers Squibb with Hold Rating, Announces Price Target of $62

Evercore ISI Group Maintains Outperform on Micron Technology, Lowers Price Target to $70